Participated · Series A · Jun 2026

Beeline Medicines is a clinical-stage biotechnology company building a focused pipeline of precision therapies rooted in validated biology. Its lead candidate, afimetoran, is a once-daily oral small molecule that targets toll-like receptors 7 and 8 (TLR7/8). Afimetoran has completed a Phase 1b trial in cutaneous lupus erythematosus and is currently in a Phase 2 study with a readout expected by year-end. The company plans to initiate a pivotal lupus trial following the Phase 2 results. Beeline emerged from stealth concurrent with announcing a $300M Series A financing led by Bain Capital. The company emphasizes durable, meaningful outcomes for patients with significant unmet needs and has assembled a leadership team that includes CEO Saqib Islam, COO and President Badreddin Edris, and CMO Nathalie Franchimont.

Participated · Series B · Jun 2026

Ollin Biosciences, founded in 2023 and based in Austin, Texas, is advancing a pipeline of bispecific antibodies for retinal and orbital diseases. Its lead candidate, OLN324, is a next-generation VEGF/Ang2 bispecific antibody discovered in collaboration with Innovent Biologics; in a 164-patient randomized head-to-head Phase 1b (JADE) study versus faricimab (Vabysmo®) OLN324 demonstrated faster and greater anatomic retinal drying and numerically greater vision gains. Ollin plans to initiate global Phase 3 trials of OLN324 in DME and wAMD in the second half of 2026 after completing regulatory discussions with the FDA and receiving EMA scientific advice. The company’s second program, OLN102, is a TSHR/IGF-1R bispecific antibody discovered with VelaVigo and is expected to enter clinical development in 2026 for thyroid eye disease and Graves’ disease. Ollin positions its candidates as potentially best-in-disease therapies and is using recent financing to fund registrational studies and further clinical development.

Led · Series F · Jun 2026

Founded in 2014 and headquartered in Boston with roots in Israel, Coralogix provides a platform that collects and analyzes operational data—logs, metrics, and traces—to detect outages, investigate incidents, and optimize applications. Its platform is used by more than 5,000 customers worldwide, including IBM, Tradeweb, and JFrog, and the company employs over 600 people globally. Coralogix grew revenue more than 60% over the past year, surpassed $100 million in annualized revenue more than a year ago, and counts roughly 30 customers spending over $1 million annually. The company competes in observability with vendors such as Datadog, New Relic, and Splunk and is embedding AI into monitoring and incident-response workflows, notably through its AI agent Olly; more than half of enterprise customers now use Olly or their own AI models to query operational data. Coralogix plans to invest further in AI-focused products, security, and international expansion while working toward profitability in the coming years.

Participated · Series C · Mar 2026

9fin combines proprietary data, analytics, and AI-driven workflows into a single platform aimed at credit professionals operating across loan, bond, and private credit markets. The company centralizes information that often resides in data rooms, emails, and PDFs to fuel its AI capabilities and speed up sourcing, analysis, and monitoring of debt opportunities. 9fin serves more than 300 banks, asset managers, law firms, and advisory firms and reports multiple consecutive years of 100% ARR growth and industry-leading retention. The firm is expanding its proprietary dataset and accelerating product development following its Series C. It is scaling its presence in the United States while maintaining offices in London, New York, Hong Kong, and Belfast. 9fin was founded by Steven Hunter and Hussam EL-Sheikh.

Led · Equity · Dec 2025

Headquartered in Miami, Boats Group runs a portfolio of digital marketplaces that have been facilitating boat and yacht transactions for more than three decades. Its platforms—Boat Trader, YachtWorld, and boats.com—collectively serve as a central hub for buyers, sellers, and dealers in the recreational marine industry. Over the past few years, the company has invested heavily in technology upgrades aimed at streamlining the end-to-end buying and selling journey, including immersive search experiences, enhanced mobile functionality, and dealer-focused tools. Boats Group is also incorporating artificial intelligence to improve merchandising, reporting, and workflow automation. Management and investors view the business as enjoying strong network effects and positioned for continued global expansion. No specific revenue, user, or profitability figures were disclosed in the article.